Skip to main content

Medicus Pharma Ltd.

MDCX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001997296

No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesMDCXW

Q4 2025 vs. Q3 2025

How the institutions holding Medicus Pharma Ltd. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of MDCX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders2021+1
Shares2.12M3.94M+1.82M (+85.9%)
Value$4.91M$6.03M+$1.12M (+22.9%)

New holders (7)

Institutions that held Medicus Pharma Ltd. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to MDCX in Q4 2025
InstitutionSharesValue% of portfolio
Armistice Capital, LLC1,810,960$2.77M0.07%
Jane Street Group, LLC60,337$92.3K0.00%
Susquehanna International Group, LLP40,162$61.4K0.00%
HRT Financial LP27,529$42.0K0.00%
Smithfield Trust Co13,883$21.0K0.00%
Two Sigma Investments, LP12,319$18.8K0.00%
Hazlett, Burt & Watson, Inc.425$1.00K0.00%

Sold out (6)

Institutions that held Medicus Pharma Ltd. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of MDCX in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Yorkville Advisors Global, LP230,000$532.5K
LPL Financial LLC18,751$43.4K
Base Wealth Management LLC11,543$26.7K
FNY Investment Advisers, LLC1,000$2.00K
EverSource Wealth Advisors, LLC300$695
Citigroup Inc222$514